Clinical Commissioning Policy: Anakinra to treat periodic fevers and autoinflammatory diseases (all ages)
This policy document outlines the arrangements for funding of treatment for periodic fevers and autoinflammatory diseases.
This policy document outlines the arrangements for funding of treatment for periodic fevers and autoinflammatory diseases.
This policy document outlines the arrangements for funding of treatment for bleeding episodes in people with acquired haemophilia A.
This policy document outlines the arrangements for funding of treatment for refractory focal onset seizures, associated with tuberous sclerosis complex, for ages 2 years and above.
This policy document outlines the arrangements for funding of treatment for homozygous familial hypercholesterolaemia.
This policy document outlines the arrangements for funding of treatment for chronic pancreatitis.
This service specification outlines the provision of a single, nationally integrated, multidisciplinary clinical and molecular diagnostic service to co-ordinate the care and management of patients with DNA nucleotide excision repair disorders.
This policy document outlines the arrangements for funding of treatment for first line treatment of mantle cell lymphoma.
This policy document outlines the arrangements for funding of treatment for corneal blindness.
This policy document outlines the arrangements for funding of treatment for first line treatment of advanced indolent non-Hodgkin’s lymphoma.
This policy document outlines the arrangements for funding of treatment for relapsed and refractory mantle cell lymphoma (all ages).